MEDIROM Healthcare Technologies Inc ADR (MRM) — Titan Protect Analysis

MRM

MEDIROM Healthcare Technologies Inc ADR

Consumer Cyclical · ·

$1.13

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$9M

Total market value of the company

Trailing P/E

3.15

Very cheap relative to earnings

Forward P/E

N/A

Based on estimated future earnings — lower means cheaper

Rev Growth

-6.7%

Year-over-year revenue change

Profit Margin

0.5%

How much profit the company keeps from each dollar of revenue

ROE

53.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

N/A

Recommendation

NONE

Consensus view from ? analysts covering this stock

About MEDIROM Healthcare Technologies Inc ADR

MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including a

https://medirom.co.jp

Country: Japan Employees: 334 Industry: Personal Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.354

Positive but modest risk-adjusted returns

Kelly Fraction

0.0066

Marginal edge — very small allocation suggested

Calmar Ratio

-0.575

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-54.1%

Historical annualised return based on price data

Max Drawdown

-94.1%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.03

Moves slightly more than the broader market

52W High

$4.45

75% below the year high

52W Low

$0.90

26% above the year low

Avg Volume

352,288

Average daily shares traded — higher means easier to buy and sell

Short Ratio

2.0

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.37

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

786.42

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

25.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-25.8%

Profit from core operations before interest and tax

Free Cash Flow

$313M

Positive — the business generates more cash than it spends

Revenue (TTM)

$8.1B

Total revenue over the last 12 months

Net Income

$40M

Profitable — the bottom line is positive

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go